Correlation between B7-H4 and Survival of Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

Reliable predictors of benefit from immune checkpoint inhibitors in non-small-cell lung cancer (NSCLC) are still limited. We aimed to evaluate the association between the expression of selected molecules involved in immune response and clinical outcomes in NSCLC patients receiving nivolumab. In our...

Descripción completa

Detalles Bibliográficos
Autores principales: Genova, Carlo, Boccardo, Simona, Mora, Marco, Rijavec, Erika, Biello, Federica, Rossi, Giovanni, Tagliamento, Marco, Dal Bello, Maria Giovanna, Coco, Simona, Alama, Angela, Vanni, Irene, Barletta, Giulia, Bianchi, Rita, Maggioni, Claudia, Bruzzi, Paolo, Grossi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832616/
https://www.ncbi.nlm.nih.gov/pubmed/31581482
http://dx.doi.org/10.3390/jcm8101566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832616/
https://www.ncbi.nlm.nih.gov/pubmed/31581482
http://dx.doi.org/10.3390/jcm8101566

Ejemplares similares